Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH) Clinical Trials

16 clinical trials for Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH) across international registries, including 8 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Phase Ⅰb/Ⅱa Clinical Study of IMC-003 Injection for the Treatment of Pulmonary Arterial Hypertension Receiving Background Therapy. — RECRUITING · PHASE1
• The Impact of ERA Switching on Risk Stratification in Pulmonary Arterial Hypertension — RECRUITING
• Study of Intravenous ZMA001 in Healthy Subjects — RECRUITING · PHASE1
• Validation of a Patient Knowledge Questionnaire for Pulmonary Hypertension — RECRUITING · NA
• Rutgers University Study of the Genetics of Pulmonary Hypertension — RECRUITING
• PulmonAry hyperteNsion DiagnOsis: a National cohoRt reseArch — RECRUITING
• Right Ventricular Compensation With Sotatercept: A Prospective Single Arm Open Label Phase 4 Study to Evaluate the Effects of Sotatercept on Right Ventricular Function in Pulmonary Arterial Hypertension (RECOMPENSE) — RECRUITING · PHASE4
• imprOving Adherence to Pulmonary artErial hyperteNsion Treatment With teLemedicIne and patieNt guidaNce — RECRUITING · NA
• A multinational, multicentre, randomized, double-blind study to assess the efficacy and safety of oral sildenafil 20mg TID or placebo when added to Bosentan in the treatement of subjects , aged 18 years and above, with pulmonary arterial hypertension (PAH) — COMPLETED · PHASE4
• Home Rehabilitation Improves Cardiac Effort in Pulmonary Arterial Hypertension — ACTIVE_NOT_RECRUITING · NA
• A Phase 3 Study of Extended-release Tacrolimus in Subjects With Pulmonary Arterial Hypertension and Functional Limitations — NOT_YET_RECRUITING · PHASE3
• Clinical Study to Compare the Efficacy and Safety of Macitentan and Tadalafil Monotherapies With the Corresponding Fixed-dose Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH) — COMPLETED · PHASE3
• Incorporating the Venous Excess Ultrasound Score (VExUS Score) Into Contemporary Haemodynamic Risk Assessment in Pulmonary Arterial Hypertension: The INVEXUS-PAH Study — COMPLETED
• The Effect of Slow-Paced Breathing on Patient Outcomes in Pulmonary Arterial Hypertension — COMPLETED · NA
• A Phase 2 Study of IkT-001Pro in Pulmonary Arterial Hypertension (PAH) — WITHDRAWN · PHASE2
• Implementing the Wuqinxi on Patients With Pulmonary Arterial Hypertension — OTHER · NA

Refine this search